Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001487732-11-000001
Filing Date
2011-11-16
Accepted
2011-11-16 17:14:59
Documents
1
Period of Report
2011-11-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4497
  Complete submission text file 0001487732-11-000001.txt   6074
Mailing Address 12117 BEE CAVES ROAD BUILDING TWO SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING TWO SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Issuer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 47350 FREMONT BLVD. FREMONT CA 94538
Business Address
Creech William B. (Reporting) CIK: 0001487732 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34810 | Film No.: 111210843